TGThe Guardian·1hHealth
score-0.65
FDA Advisory Panel Calls for Clearer Regulatory Framework Around Popular Injectable Peptides Amid Safety Review Debate
Original
US health panel recommends easing restrictions on controversial peptides
“Alarmist framing emphasizes industry conflicts of interest, safety warnings from government scientists, and lack of evidence—with minimal counterargument.”